bf/NASDAQ:MRNA_icon.jpeg

NASDAQ:MRNA

Moderna Inc.

  • Stock

USD

Last Close

24.33

06/11 22:31

Market Cap

45.01B

Beta: 1.70

Volume Today

14.83M

Avg: 3.57M

PE Ratio

−10.50

PFCF: −13.71

OverviewFinancialsAPI

    Description

    Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    5102017-12-312019-05-092021-05-062023-05-042025-02-14

    Revenue (Estimate*)

    1B2B3B4B5B6B7B2017-12-312019-05-092021-05-062023-05-042025-02-14

    *Estimate based on analyst consensus